KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Return on Capital Employed (2019 - 2025)

Historic Return on Capital Employed for Vir Biotechnology (VIR) over the last 7 years, with Q3 2025 value amounting to 0.53%.

  • Vir Biotechnology's Return on Capital Employed fell 1200.0% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year decrease of 1200.0%. This contributed to the annual value of 0.38% for FY2024, which is 700.0% down from last year.
  • Vir Biotechnology's Return on Capital Employed amounted to 0.53% in Q3 2025, which was down 1200.0% from 0.53% recorded in Q2 2025.
  • Vir Biotechnology's 5-year Return on Capital Employed high stood at 0.93% for Q1 2022, and its period low was 0.58% during Q1 2021.
  • Moreover, its 5-year median value for Return on Capital Employed was 0.35% (2024), whereas its average is 0.13%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 15000bps in 2022, then crashed by -10700bps in 2023.
  • Vir Biotechnology's Return on Capital Employed (Quarter) stood at 0.34% in 2021, then increased by 10bps to 0.37% in 2022, then crashed by -202bps to 0.38% in 2023, then fell by -17bps to 0.44% in 2024, then dropped by -20bps to 0.53% in 2025.
  • Its last three reported values are 0.53% in Q3 2025, 0.53% for Q2 2025, and 0.53% during Q1 2025.